Unicycive Therapeutics Stock (NASDAQ: UNCY) stock price, news, charts, stock research, profile.
You can purchase shares of Unicycive Therapeutics (NASDAQ:UNCY) through any online brokerage.
Other companies in Unicycive Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), PepGen (NASDAQ:PEPG), Vistagen Therapeutics (NASDAQ:VTGN) and OS Therapies (AMEX:OSTX).
Unicycive Therapeutics has a consensus price target of $5.50.
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $0.665 last updated January 10, 2025 at 7:49 PM EST.
There are no upcoming dividends for Unicycive Therapeutics.
Unicycive Therapeutics’s Q4 earnings are confirmed for Thursday, March 27, 2025.
There is no upcoming split for Unicycive Therapeutics.
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.